Euro-ophthalmology Market Analysis and Reports | Ireland Conference Series

Market Analysis - Euro-ophthalmology 2018

Ophthalmology Congress 2018 Scope and Market Research:

According to a study it is estimated that around 48% of world population is blind because of cataract and more than 60 million people suffer from glaucoma and it is estimated that the number would rise to 80 million by the end of 2020. Ageing population is the leading cause for refractive error problem in countries like the USA and Europe, it is noticed that the refractive error problem is mostly seen in population ageing more than 40 years.

After a huge downfall of the market during economic drain in 2008-2009, ophthalmology market is catching up to get back to the normal as there is a rapid growth in population resulting in increased number of patients with eye diseases and the incidence of cataract and glaucoma are increasing every year.

Importance and scope:

The field of Ophthalmology: Ocular treatment & care is growing rapidly and its development is making tremendous impacts in medical and health sciences and pharmaceuticals. The importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors. Ophthalmology Congress 2017 conference will concentrate on latest and exciting innovations in areas of eye surgeries, diagnostics and recent technologies towards eye care. It will also provide an excellent opportunity to meet the leading eye surgeons, top class eye care specialists, ophthalmologists, optometrists, research scientists and the young student research community working the related field.

Ophthalmology Congress 2017 Conference is designed to comprise of Keynote sessions, Workshops and focused symposium on latest developments in the field of one of the sense organ Eye health. The three-day Ophthalmology -2017 conference includes major sessions on detailed overview on Retinal diseases and disorders, Research Trends in Surgical and Medical Ophthalmology, Novel Approaches to Ophthalmology Therapeutics, Ocular-Pathology, Optometry and vision science. Ophthalmology Summit 2017 also acts as a platform to exchange information, new interventions and strengthen the collaboration among Ophthalmologists, Optometrists, Researchers, Associate Professors, and Scholars from both academia and ophthalmic Institutes.

According to WHO :

  • 285 million people are estimated to be visually impaired worldwide: 39 million are blind and 246 have low vision.
  • About 90% of the world’s visually impaired live in low-income settings.
  • 82% of people living with blindness are aged 50 and above.
  • Globally, uncorrected refractive errors are the main cause of moderate and severe visual impairment; cataracts remain the leading cause of blindness in middle- and low-income countries.
  • The number of people visually impaired from infectious diseases has reduced in the last 20 years according to global estimates work.
  • 80% of all visual impairment can be prevented or cured.
  • Cataract removal is the most commonly performed ophthalmic surgical operation.

SIFI is the leading Italian ophthalmic company, focused on eye care since 1935. SIFI designs, manufactures and markets innovative pharmaceutical specialty products, surgical and medical devices. Headquartered in Catania, Sicily, SIFI operates directly in Italy, Romania and Mexico with a staff of more than 350 people worldwide. Since June 2015, SIFI is backed by 21 Investimenti, a private equity firm founded by Alessandro Benetton, which supports the company’s international expansion and portfolio development strategy.

Fund Allotment to Ophthalmology Treatments and Research: The Ophthalmology Department at Upstate Medical University has received a $110,000 unrestricted grant from Research to Prevent Blindness (RPB), bringing the department’s total amount of RPB funding to more than $2.6 million since 1998. In addition to RPB funding, Upstage’s Ophthalmology Department has attracted more than $22.7 million in peer-reviewed funding from the National Institutes of Health, National Science Foundation and other agencies and lists among its funding sources $1.2 million from the Grateful Patient campaign of the Upstate Medical University Foundation and $250,000 from the Lions Clubs of District

The NEI is operating under a continuing resolution (H. R. 2775/Public Law 113-46), which provides $195M to fund operations. See $10M is allocated to Research Management Support, $24M to the Intramural Research Program, and $161M to Extramural Research.

Conference Highlights:

  • Retina & its Disorders
  • Cornea Disorders and Treatments
  • Glaucoma
  • Ophthalmology Surgery
  • Ocular Microbiology
  • Ocular Oncology
  • Ophthalmic Disorders
  • Pediatric Ophthalmology
  • Neuro Ophthomology
  • Advanced Ophthalmological Care
  • Optometry and Vision Science
  • Orbital Disorders
  • Eye Floater and Vision
  • Ophthalmic Drug Delivery
  • Ophthalmology Practice
  • Entrepreneurs Investment Meet

Target Audience:   Ophthalmologist, Optometrists, Researchers, Eye surgeons, Physicians, Eye care specialists,   Professors, Scientific Community, Delegates and Students are the main participants for the conference. Business professionals (Directors, Presidents, CEO) from Ophthalmology equipment companies.

Members associated with ophthalmology research:

•             American Academy of Ophthalmology


•             Afro-Asian Council of Ophthalmology


•             All India Ophthalmological Society


•             Asia Pacific Academy of Ophthalmology


•             Canadian Ophthalmological Society


•             Chinese Ophthalmological Society


•             Canadian Ophthalmological Society


•             Danish Ophthalmological Society


•             European Society of Ophthalmology


•             French Society of Ophthalmology


•             German Ophthalmological Society


•             Italian Society of Ophthalmology


•             Japanese Ophthalmological Society


•             Korean Ophthalmological Society


•             Malaysian Society of Ophthalmology


•             Ophthalmological Society of South Africa


•             Ophthalmic Society Emirates Medical Association


•             Royal College of Ophthalmologists, United Kingdom


•             Saudi Ophthalmological Society


•             Major Associations related to Eye in USA:


•             American Academy of Ophthalmology


•             American Academy of Optometry


•             American Board of Ophthalmology


•             American Council of the Blind


•             American Uveitis Society


•             Maryland Society of Eye Physicians & Surgeons


•             American Academy of Ophthalmology


•             American Academy of Optometry


•             American Association for Pediatric Ophthalmology and Strabismus


•             American Association of the Deaf-Blind (AADB)


•             American Autoimmune Related Diseases Association, Inc.


•             American Behcet's Disease Association


•             American Board of Ophthalmology


•             American College of Medical Genetics (ACMG)


•             American Council of the Blind


•             American Diabetes Association


•             American Foundation for the Blind


•             American Optometric Association


•             Christian Record Services for the Blind


•             Glaucoma Research Foundation


•             Vision USA

Companies in Europe

  • Novartis
  • Lucentis
  • Aerpio Therapeutics
  • Alcon
  • Allen & Hanburys Ltd
  • Actelion Pharmaceuticals UK Ltd
  • Altana Pharma Ltd
  • Arrow Generics UK Ltd
  • AS Pharma Ltd
  • Bausch & Lomb UK Ltd
  • Baxter International
  • Beacon Pharmaceuticals Ltd
  • Concord Pharmaceuticals Ltd
  • Crawford Pharmaceuticals
  • Goldshield Pharmaceuticals Ltd
  • GP Pharma
  • GlaxoSmithKline
  • Hamelin Pharmaceuticals
  • Paul Hartmann Ltd
  • Hawgreen Ltd
  • Henleys Medical Supplies Ltd
  • Huntley Pharmaceuticals Ltd
  • Hybrand Ltd
  • Intrapharm Laboratories Ltd
  • Pfizer Ltd
  • MDE Diagnostics Europe Ltd
  • Mead Johnson Nutritionals
  • Meadow Laboratories Ltd
  • Medlock Medical Ltd
  • Menarini Diagnostics
  • Merck Pharmaceuticals
  • Micro Medical Ltd
  • Merck & Co. Ltd
  • Myogen – Myogen GmbH
  • Nagor Ltd
  • Nestlè UK Ltd
  • Network Health & Beauty

Companies Worldwide

  • Abbott
  • Acucela
  • Aerie Pharmaceuticals
  • Aerpio Therapeutics
  • Akorn
  • Alimera Sciences
  • Altheos
  • Amakem
  • Ampio Pharmaceuticals
  • Bayer
  • BioDiem
  • Eleven Biotherapeutics
  • EyeGate Pharmaceuticals
  • Gene Signal
  • Icon Bioscience
  • Lpath
  • MacuCLEAR
  • Neurotech
  • Omeros
  • Ophthotech
  • Otsuka Pharmaceutical
  • RXi Pharmaceuticals
  • Shire
  • Sirnaomics
  • ThromboGenics
  • Allergan
  • Merck
  • Pfizer
  • Regeneron
  • Alimera Sciences
  • Accuitis Pharmaceuticals
  • Iris Pharma
  • BioPharmGuy
  • Clearside Biomedical
  • Santen Pharmaceutical Co., Ltd.
  • S J Pharmaceuticals
  • Mikart Inc
  • McKesson Corporation
  • Barr and Stroud
  • Bausch & Lomb
  • Boston Micro machines Corporation
  • Bushnell Corporation
  • Keystone View Company
  • Quantel Medical
  • Icare USA
  • Ophthalmic World LLC    
  • Gilead Sciences
  • Amgen
  • Watson Pharmaceuticals
  • Santen
  • Eylea
  • Hyalein
  • Cosopt
  • Tapros/Taflotan
  • Diquas
  • Cravit and Tarivid

Universities in Europe

  • Lancaster University
  • Bangor University
  • Cardiff University
  • Loughborough University
  • National University of Ireland Maynooth
  • Newcastle University
  • Royal Holloway, University of London
  • University of Birmingham
  • University of Cambridge
  • University of Edinburgh
  • University of Glasgow
  • University of Kent
  • University of Leicester
  • University of Nottingham
  • University of Oxford
  • University of Turku, Finland
  • University of York
  • University of Zurich
  • European College of Veterinary Ophthalmologists

Universities Worldwide

  • Duke University School of Medicine
  • University of California, San Francisco
  • Johns Hopkins University
  • University of Pennsylvania
  • University of Washington Seattle
  • University of California, Los Angeles
  • University of Michigan at Ann Arbor
  • University of North Carolina Chapel Hill
  • University of Pittsburgh
  • University of Chicago
  • Washington University, Saint Louis
  • University of Florida
  • Brown University
  • University of California, San Diego
  • University of Iowa
  • University of California Davis
  • Baylor University, Houston
  • Vanderbilt University, Nashville
  • Columbia University
  • La Trobe University
  • University of Vermont
  • University of Louisville
  • Rush University Medical Center
  • Loyola University Health System
  • University of Illinois
  • University of Missouri School of Medicine
  • The University of Utah
  • Stanford University
  • University of Iowa
  • University of British Columbia
  • University of Alberta
  • Yale University
  • Case Western Reserve University
  • University of Alabama School of Medicine
  • University of Cincinnati Medical Center
  • Indiana University
  • University of Arkansas
  • OHIO University
  • Aberdeen University
  • The Royal College of Ophthalmologists
  • Emory University, Atlanta
  • Mercer University School of Medicine
  • Morehouse School of Medicine
  • American Inter Continental University
  • Medical College of Georgia (MCG)
  • Georgia Health Sciences University

Number of Hospitals in Europe

  • Rutnin Eye Hospital
  • St. Erik Eye Hospital
  • The Royal Victoria Eye and Ear Hospital
  • Tokuda Hospital
  • Wellington Eye Clinic Dublin
  • Eye and Dental Clinic
  • Biomedica International SRL
  • Dr. Vryghem Clnic
  • The Stratford Clinic
  • Hospital Particular do Algarve
  • Mediterranean Health Care
  • St. Francis Private Hospital
  • New Vision

Number of Hospitals Worldwide

  • Royal Perth Hospital, Perth
  • Lions Eye Institute, Nedlands
  • St John of God Hospital, Subiaco
  • Kellogg Eye Center
  • Vasan Eye Care
  • Narayana Nethralaya
  • Manipal Eye Care
  • Johns Hopkins Hospital
  • Alipurduar Lions Eye Hospital
  • Magrabi Eye Hospital
  • Wills Eye Hospital
  • St. Vincent's university hospital
  • Sydney Eye Hospital
  • St. Thomas' Hospital
  • London Eye Hospital
  • Macquarie University Hospital Ophthalmology
  • The Cataract Clinic
  • Canberra Eye Hospital
  • Cataract Care Centre
  • Emory Eye Center
  • Piedmont Hospital
  • St. Joseph's Hospital of Atlanta
  • Jules Stein Eye Institute
  • Advanced Vision Care, Los Angeles
  • Mid Florida Eye Center

Market Analysis and Report

Global ophthalmology drug and devices market is witnessing a significant growth these days due to the increasing incidence and prevalence of eye related disorders such as macular degeneration, presbyopia, and diabetic retinopathy among the todays aging population. With the introduction of ophthalmic devices equipped with sophisticated technologies, people are increasingly opting for ophthalmic surgeries to correct their eye related disorders for having a healthy life. The global ophthalmology market witnessed a dip during the economic downturn in 2008 and 2009; however, it is poised to grow at a stable rate mainly due to an increasing aging population, large group of patients with eye diseases, changing demographics and geographical trends, and increased focus on combination therapies of drugs. Moreover, incidences of retinal disease, glaucoma and cataract are increasing every year.

Lack of health insurance amongst population especially within the developing countries or lack of insurance covering all types of IOLs or contact lens in developed countries is a significant challenge faced by the ophthalmology industry. The other challenges include low awareness about the ophthalmic disorders, especially in developing countries. This is primarily due to the lack of awareness amongst rural population about the various ophthalmic disorders. The ophthalmology drugs and devices market is divided into four major segments are surgical devices, diagnostic and monitoring devices, vision care, and drugs. Drugs market is classified into existing treatment drugs and drugs in pipeline and the vision care market is segmented into spectacles and contact lenses. The total market is forecasted till 2017. This market is also considered by formulation types such as capsules, gels, eye drops, ointment, and eye solutions.

Advancements in ophthalmic technologies, high prevalence rates of refractive error, cataract, and glaucoma, increasing demand for the diagnostic procedures and low compliance with pharmaceuticals will propel this devices market. The Global Ophthalmology Drug and Devices Market is expected to reach a market size of $36 billion by the year 2014, at a CAGR of 5.4% from 2009-2014. The drugs market is expected to reach a size of $19.8 billion by the year 2014 growing at a CAGR of 4% from 2009-2014. Europe is the second largest market for ophthalmology drugs and devices, followed by Asia.

Market estimates and forecast

The report provides in-depth market estimates and forecast for ophthalmology devices based on major eye disorders such as cataract, refractive error and other retinal disorders. It segments the global ophthalmology drugs market on the basis of treatment based drugs, OTC drugs and anesthetics.

Global ophthalmology market by products

  • Diagnostic and monitoring devices
  • Surgical devices
  • Vision care
  • Drugs

Diagnostic and monitoring devices

•             Optical Coherence Tomographers (OCT)

•           Ophthalmic ultrasound imaging systems

•           Fundus cameras

•           Ophthalmoscopes

•           Retinoscopes

•           Wavefront aberrometer

•           Corneal topographer

•           Autorefractors/Phoropters

•           Pachymeters

•           Keratometers

•           Specular microscopes

•           Biometers

•           Visual field analysers/Perimeter

•           Tonometers

•           Slit lamps

•           Optotype projectors

•           Dioptometers

Vision care

•             Contact lenses

•           Spectacles

Surgical devices Market

•           Cataract

1.         Intraocular Lens (IOL)

2.         Ophthalmic Viscoelastic Devices (OVD)

3.         Phacoemulsification Devices

•           Glaucoma

1.         Glaucoma Drainage Devices (GDD)

2.         Stents and Implants

3.         Glaucoma Lasers

4.         Glaucoma Systems

•           Refractive error

1.         Excimer Laser

2.         YAG Laser

3.         Microkeratome

4.         Femtosecond Laser

•           Vitreoretinal

1.         Vitrectomy Machines

2.         Photocoagulation Lasers

3.         Illumination Devices

Global ophthalmology drugs market, by indication:

•             Glaucoma

•           Retinal disorders (Age-related Macular Degeneration (AMD), Diabetic retinopathy, Macular edema)

•           Dry eye

•           Allergy/Inflammation/Conjunctivitis

The report only covers those drugs that are in late Phase 3 or those that have cleared Phase 3 clinical trials for pipeline analysis and forecasting.

Ophthalmology devices market, by geography

•           North America

•           Europe

•           Asia

•           Rest of the World (RoW)

Ophthalmology drugs market, by geography

•           U.S.

•           Europe

•           Asia

•           Japan

•           Rest of the World (RoW)

The 27th  European Ophthalmology Conference which is going to be held during November 26-28, 2018 Dublin, Ireland, which brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostic companies, leading universities and clinical research institutions making the conference a perfect platform to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe. Ophthalmology Congress maximizes the opportunity to interact with and learn from your peers from across the country and across the globe it held with the discussions on Cornea and External Eye Disease, Retina and Retinal Disorders, Neuro-Ophthalmology, Glaucoma: Visual Field Loss, Ocular Microbiology and Immunology, Novel Approaches to Ophthalmology Therapeutics and many more.